Research materials for laboratory use only

Free UK delivery from £25 · Same-day dispatch · Tracked European delivery

Customer support
Tesamorelin illustrative boxed research pen image
Research pen

Tesamorelin 5 mg total per pen

Listed amount

£35.00

1

Tesamorelin research material, shown as a boxed pen.

Pen imagery is illustrative, based on supplied reference photographs. It does not verify the final supplied hardware, fill or strength.

Supplied for laboratory and scientific research only. Not for human or veterinary use.

Product specifications

NameTesamorelin
CategoryResearch pen
Listed amount5 mg total per pen
FormatBoxed research pen concept — final fill and concentration are unconfirmed
ClassificationSupplied for laboratory and scientific research only. Not for human or veterinary use.

Shipping and support

Free UK delivery when you spend £25 or more. Eligible in-stock orders are dispatched the same working day, with tracked delivery available to selected European destinations.

Choose your country at checkout to confirm product availability and delivery charges.

Delivery windows are estimates, not guarantees. Dispatch is not the same as delivery, and customs clearance is not controlled by Zynx.

Documentation

Supporting quality documentation is displayed where available.

View quality documentation · Research-use policy · Delivery · Returns. Batch and Certificate of Analysis lookup is not available on this site.

Research references

Published papers describe research on the named compound or related molecules. They do not test, certify or endorse the specific material shown on this page, and they do not make the material approved for personal use.

Human randomised trial

Metabolic effects of a growth hormone-releasing factor in patients with HIV

New England Journal of Medicine, 2007

Study model: Adults with HIV-associated abdominal fat accumulation

A randomised trial of a growth hormone-releasing factor in people with HIV-associated abdominal fat accumulation.

Findings apply to the studied HIV-associated population and trial formulation. They do not generalise automatically and do not test the listed research material.

Human randomised trial

Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation

JAMA, 2014

Study model: HIV-infected adults with abdominal fat accumulation

A randomised clinical trial measuring visceral and liver fat after tesamorelin in a defined HIV-associated population.

Keep the study population in view. Results should not be generalised to unrelated groups, and the paper does not test the listed product.

Tesamorelin5 mg total per pen · £35.00